{"brief_title": "Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion", "brief_summary": "This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).", "condition": "Thrombosis", "intervention_type": "Drug", "intervention_name": "Alfimeprase", "criteria": "- Patients with acute peripheral arterial occlusion of the lower limb (onset of symptoms within 14 days) - Rutherford Class I or IIa (minimal sensory loss, no muscle weakness, audible venous flow) - Age 18 or above - Able to consent - Able to follow up", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00073554.xml"}